BRAINSTORM CELL THERAPEUTICS INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2025-11-14: Form 8-K; Exhibit 10.2; Description Promissory Note, issued October 10, 2025, to Labrys Fund II, L.P..
- 2025-11-14: Form 8-K; Exhibit 10.1; Description Securities Purchase Agreement, dated November 10, 2025, between the Company and Labrys Fund II, L.P..
- 2025-11-06: Form 8-K; Exhibit 10.2; Description Promissory Note, issued October 31, 2025, to Vanquish Funding Group Inc..
- 2025-11-06: Form 8-K; Exhibit 10.1; Description Securities Purchase Agreement, dated October 31, 2025, between the Company and Vanquish Funding Group Inc..
| Filed | Form | Exhibit | Description |
|---|
| 2025-11-14 | 8-K | 10.2 | Promissory Note, issued October 10, 2025, to Labrys Fund II, L.P. |
|---|
| 2025-11-14 | 8-K | 10.1 | Securities Purchase Agreement, dated November 10, 2025, between the Company and Labrys Fund II, L.P. |
|---|
| 2025-11-06 | 8-K | 10.2 | Promissory Note, issued October 31, 2025, to Vanquish Funding Group Inc. |
|---|
| 2025-11-06 | 8-K | 10.1 | Securities Purchase Agreement, dated October 31, 2025, between the Company and Vanquish Funding Group Inc. |
|---|
| 2025-06-25 | 8-K | 10.12 | Amendment No. 5 to Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan. |
|---|
| 2025-06-25 | 8-K | 10.6 | Amendment No. 5 to Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan. |
|---|
| 2025-03-31 | 10-K | 10.83 | Employment Agreement, dated as of June 27, 2023 by and between Brainstorm Cell Therapeutics Ltd. and Ibrahim B. Dagher |
|---|
| 2025-03-31 | 8-K | 10.1 | Form of Warrant Inducement Agreement, by and between the Company and the Holder identified on the signature page thereto |
|---|